Pfizer-BioNTech Vaccine Approval
Tuesday, 2 December United Kingdom government announced the first emergency approval of the Pfizer-BioNTech Covid-19 vaccine. After critical testing and regulation, the vaccine has received approval.
Medicines And Healthcare Products Regulatory agency officially announced-
Subsequently, the United Kingdom became the first country to approve the first Covid-19 Vaccine. Moreover, the vaccine distribution will commence from next week.
The Process To Approval- ‘Rolling Review’
The UK govt. website explains how using ‘Rolling Review’ helped approve the vaccine.
The ‘Rolling Review’ is to analyze medicines at the time of emergency. Through data of the progressive studies, thee analysis is conducted.
The Secretary of State for Health and Social Care- Matt Hancock expressed through Twitter
Pfizer- BioNTech claims that the vaccine efficacy is 90% in preventing Covid-19.
The vaccine development is in collaboration with Germany Based BioNTech-Group and Pfizer. This partnership expects to deliver over 1.3 million doses in 2021. Hence, promises to increase supply globally. While continuously improving facilities and infrastructure.
Who Receives The Vaccination First?
Since the vaccination programme most probably will start next week in the UK. Care home elderly and health care people are on the priority list. Above all, 40 million doses have been ordered by the government. Though, transportation and supply don’t seem a cakewalk. The government is strategizing adequately.
Still, people are skeptical about the vaccine. However, show readiness to get inoculated. Similarly, the authorization has given temporary approval-meaning that the approval comes with a certain set of restrictions.
In Addition to this, the National Institute For Biological Standards and Control will be continuously monitoring the use, supply, and regulate the vaccination procedure. The government is already receiving applauds from different parts of the world.
Finally, it would be interesting to know how the decision will turn out. Besides, how it will impact the approval of other vaccines and approval in other countries.
Author: Mansi Goel
Reference-> UK gov
Feature Image Reference– Aljazeera